Diagnosis and management of FSHD

A report has been published on standards of care and clinical trial readiness for facioscapulohumeral muscular dystrophy (FSHD). The report is based on the outcomes of a European Neuromuscular Centre (ENMC) workshop held in the Netherlands in January of this year. FSHD is the third most common muscle disorder and although no definite cure exists, careful management of the symptoms can lead to significant improvements in quality of life. The report was published in Neuromuscular Disorders [20(7):471-5].